Evidence map›Paper›PMID 41844092›Full record

ArticleVaccine2026

Targeted mutagenesis in Ehrlichia canis deleting the phage head-to-tail connector protein gene and its assessment as a vaccine candidate preventing canine ehrlichiosis.

Dominica D Ferm, Arathy Nair, Jonathan D Ferm, Huitao Liu, Ying Wang, Liliana F Crosby, Jodi McGill, Perle Latre De Late, Ian Stoll, Deepika Chauhan and 7 more

Abstract read
In one paragraph

Article in Vaccine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Dominica D FermDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Center of Excellence for Vector-Borne Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Arathy NairCenter of Excellence for Vector-Borne Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Jonathan D FermDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Center of Excellence for Vector-Borne Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Huitao LiuDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Center of Excellence for Vector-Borne Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Ying WangCenter of Excellence for Vector-Borne Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Liliana F CrosbyDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Jodi McGillDepartment of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA.
Perle Latre De LateDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Ian StollDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Deepika ChauhanDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Debika ChoudhuryDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Swetha MadeshDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Suhasini GantaDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Alexandra BurneDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Sezayi OzubekDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Anish YadavDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA.
Roman R GantaDepartment of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, Bond Life Sciences Center, University of Missouri, Columbia, MO, USA; Center of Excellence for Vector-Borne Diseases, Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA. Electronic address: romanganta@missouri.edu.

Funding

Vector and Host Contributions to the Regulation of E. Chaffeensis Gene ExpressionR01AI070908 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROMAN R. GANTA · 2008 to 2026
$6.9M
Vaccines Against Ehrlichia and Anaplasma Species InfectionsR01AI152418 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI GANTA, ROMAN R. · 2020 to 2024
$3.1M
Genetics and Axenic Growth of tick-borne E. chaffeensis and A. phagocytophilumR01AI182519 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ROMAN R. GANTA · 2024 to 2026
$1.6M
Vector and Host Contributions to the Regulation of E. chaffeensis Gene ExpressionR56AI070908 · NIAID · KANSAS STATE UNIVERSITY · PI GANTA, ROMAN R. · 2013 to 2013
$426k
NIAID NIH HHS R01 AI070908NIAID NIH HHS R01 AI152418NIAID NIH HHS R01 AI182519NIAID NIH HHS R56 AI070908
6 · The paper itself

Abstract

Ehrlichia canis is primarily a Rhipicephalus sanguineus tick-borne rickettsial pathogen initially identified as causing canine monocytic ehrlichiosis, and human infections have also been reported in Venezuela, Mexico, and parts of Europe. It is of high importance to have a vaccine suitable in protecting the canine host, which will aid in lessening E. canis infections also in humans. Gene inactivation mutations in the phage head-to-tail connector protein genes (phtcp) from E. chaffeensis and A. marginale caused attenuated growth, and prior infection with the mutated bacteria induced protective immunity against wild-type bacterial infections in the natural hosts, independent of infection acquisition from blood-borne infection or tick-transmission. In the current study, we describe the development of targeted mutagenesis for the first time in E. canis genome and with a novel modification to avoid introducing antibiotic resistance cassettes to delete the phtcp ortholog from E. canis. The mutated E. canis was then assessed for its in vivo growth and the induction of host immunity exerted following the mutant infection aiding to protect against wild-type infection challenge in the canine host. We assessed systemic infection, hematological parameters, immune responses, and plasma cytokines following the mutant infection relative to uninfected dogs. Similarly, the assessments were carried out following wild-type pathogen infections in dogs with or without prior mutant infection challenges. The study demonstrates that prior infection of dogs with the mutant induces immunity to prevent infection establishment by wild-type E. canis. Similarly, the mutant infection resulted in clear biological differences compared to the wild-type infection. This study establishes that the molecular genetic methods are broadly applicable to pathogens belonging to the family Anaplasmataceae and that the modified live vaccines with functional defects in phtcp gene orthologs are valuable in reducing the diseases caused by the tick-borne rickettsial pathogens belong to Anaplasmataceae, including E. canis.

Indexed as

Bacterial VaccinesDog DiseasesEhrlichia canisEhrlichiosisAnimalsBacterial ProteinsBacteriophagesDogsMutagenesisBacterial ProteinsBacterial VaccinesAnaplasmataceae pathogenCanine monocytic ehrlichiosisCanine vaccineEhrlichia canisEhrlichiosisModified live vaccineRickettsial diseaseRickettsial geneticsTargeted mutagenesis in obligate intracellular bacteriaTick-borne disease

Identifiers

PMID41844092
PMCPMC13077643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.